Viremia after one month of interferon therapy predicts treatment outcome in patients with chronic hepatitis C

Viremia after one month of interferon therapy predicts treatment outcome in patients with chronic hepatitis C

BACKGROUND & AIMS: In chronic hepatitis C, interferon alfa induces sustained remission in less than 30% of treated patients. The aim of this study is to analyze viral status early after initiation interferon therapy as a predictor of treatment outcome. METHODS: One hundred eighty-one pati...

Full description

Bibliographic Details
Main Authors: Gavier, B. (B.), Martinez-Gonzalez, M.A. (Miguel Ángel), Riezu-Boj, J.I. (José Ignacio), Lasarte, J.J. (Juan José), Garcia, N. (Nicolás), Civeira, M.P. (María Pilar), Prieto, J. (Jesús)
Format: info:eu-repo/semantics/article
Language:eng
Published: WB Saunders 2012
Subjects:
Antiviral Agents/therapeutic use
Hepatitis C/therapy
Interferon-alpha/therapeutic use
Viremia/therapy
Online Access:https://hdl.handle.net/10171/21677

Internet

https://hdl.handle.net/10171/21677

Similar Items